-
-
-
-
-
-
-
Wedbush Downgrades Mersana (MRSN) to Neutral
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
Mersana Therapeutics (MRSN) Misses Q2 EPS by 3c
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

